198 related articles for article (PubMed ID: 27379746)
21. Synthesis and antimicrobial properties of N-substituted derivatives of (E)-2',3″-thiazachalcones.
Usta A; Taşkıran H
Z Naturforsch C J Biosci; 2015; 70(1-2):45-50. PubMed ID: 25854843
[TBL] [Abstract][Full Text] [Related]
22. Synthesis, SAR and antibacterial studies on novel chalcone oxazolidinone hybrids.
Selvakumar N; Kumar GS; Azhagan AM; Rajulu GG; Sharma S; Kumar MS; Das J; Iqbal J; Trehan S
Eur J Med Chem; 2007 Apr; 42(4):538-43. PubMed ID: 17150281
[TBL] [Abstract][Full Text] [Related]
23. Synthesis of newer 1,2,3-triazole linked chalcone and flavone hybrid compounds and evaluation of their antimicrobial and cytotoxic activities.
Kant R; Kumar D; Agarwal D; Gupta RD; Tilak R; Awasthi SK; Agarwal A
Eur J Med Chem; 2016 May; 113():34-49. PubMed ID: 26922227
[TBL] [Abstract][Full Text] [Related]
24. Pinocembrin chalcone: an antibacterial compound from Helichrysum trilineatum.
Bremner PD; Meyer JJ
Planta Med; 1998 Dec; 64(8):777. PubMed ID: 9933997
[No Abstract] [Full Text] [Related]
25. Bioactive Formylated Flavonoids from Eugenia rigida: Isolation, Synthesis, and X-ray Crystallography.
Zaki MA; Nanayakkara NP; Hetta MH; Jacob MR; Khan SI; Mohammed R; Ibrahim MA; Samoylenko V; Coleman C; Fronczek FR; Ferreira D; Muhammad I
J Nat Prod; 2016 Sep; 79(9):2341-9. PubMed ID: 27618204
[TBL] [Abstract][Full Text] [Related]
26. Synthesis, characterization, theoretical, anti-bacterial and molecular docking studies of quinoline based chalcones as a DNA gyrase inhibitor.
Abdullah MI; Mahmood A; Madni M; Masood S; Kashif M
Bioorg Chem; 2014 Jun; 54():31-7. PubMed ID: 24747187
[TBL] [Abstract][Full Text] [Related]
27. Spasmolytic flavonoids from Syzygium samarangense (Blume) Merr. & L.M. Perry.
Amor EC; Villaseñor IM; Ghayur MN; Gilani AH; Choudhary MI
Z Naturforsch C J Biosci; 2005; 60(1-2):67-71. PubMed ID: 15787247
[TBL] [Abstract][Full Text] [Related]
28. Structure-activity relationship of antibacterial chalcones.
Avila HP; Smânia Ede F; Monache FD; Smânia A
Bioorg Med Chem; 2008 Nov; 16(22):9790-4. PubMed ID: 18951808
[TBL] [Abstract][Full Text] [Related]
29. Antifungal activity and studies on mode of action of novel xanthoxyline-derived chalcones.
Boeck P; Leal PC; Yunes RA; Filho VC; López S; Sortino M; Escalante A; Furlán RL; Zacchino S
Arch Pharm (Weinheim); 2005 Mar; 338(2-3):87-95. PubMed ID: 15799012
[TBL] [Abstract][Full Text] [Related]
30. Thermal solvent-free synthesis of chromonyl chalcones, pyrazolines and their in vitro antibacterial, antifungal activities.
Siddiqui ZN; Praveen S; Musthafa TN; Ahmad A; Khan AU
J Enzyme Inhib Med Chem; 2012 Feb; 27(1):84-91. PubMed ID: 21612378
[TBL] [Abstract][Full Text] [Related]
31. Synthesis and Regioselective Reaction of Some Unsymmetrical Heterocyclic Chalcone Derivatives and Spiro Heterocyclic Compounds as Antibacterial Agents.
El-Hashash MA; Rizk SA; Atta-Allah SR
Molecules; 2015 Dec; 20(12):22069-83. PubMed ID: 26690393
[TBL] [Abstract][Full Text] [Related]
32. Improved small-molecule macroarray platform for the rapid synthesis and discovery of antibacterial chalcones.
Stringer JR; Bowman MD; Weisblum B; Blackwell HE
ACS Comb Sci; 2011 Mar; 13(2):175-80. PubMed ID: 21210707
[TBL] [Abstract][Full Text] [Related]
33. 1H and 13C NMR spectral assignments of chalcones bearing pyrazoline-carbothioamide groups.
Yoon H; Ahn S; Park M; Kim DW; Kim SH; Koh D; Lim Y
Magn Reson Chem; 2013 Aug; 51(8):500-8. PubMed ID: 23784987
[TBL] [Abstract][Full Text] [Related]
34. Thiazole-based chalcones as potent antimicrobial agents. Synthesis and biological evaluation.
Liaras K; Geronikaki A; Glamočlija J; Cirić A; Soković M
Bioorg Med Chem; 2011 May; 19(10):3135-40. PubMed ID: 21524583
[TBL] [Abstract][Full Text] [Related]
35. Design of potent fluoro-substituted chalcones as antimicrobial agents.
Burmaoglu S; Algul O; Gobek A; Aktas Anil D; Ulger M; Erturk BG; Kaplan E; Dogen A; Aslan G
J Enzyme Inhib Med Chem; 2017 Dec; 32(1):490-495. PubMed ID: 28118738
[TBL] [Abstract][Full Text] [Related]
36. Synthesis, physicochemical properties and antimicrobial evaluation of new (E)-chalcones.
Nowakowska Z; Kedzia B; Schroeder G
Eur J Med Chem; 2008 Apr; 43(4):707-13. PubMed ID: 17618710
[TBL] [Abstract][Full Text] [Related]
37. Antimicrobial and cytotoxicity potential of acetamido, amino and nitrochalcones.
Tristão TC; Campos-Buzzi F; Corrêa R; Cruz RC; Cechinel Filho V; Bella Cruz A
Arzneimittelforschung; 2012 Dec; 62(12):590-4. PubMed ID: 23086581
[TBL] [Abstract][Full Text] [Related]
38. Synthesis and antibacterial evaluation of novel cationic chalcone derivatives possessing broad spectrum antibacterial activity.
Chu WC; Bai PY; Yang ZQ; Cui DY; Hua YG; Yang Y; Yang QQ; Zhang E; Qin S
Eur J Med Chem; 2018 Jan; 143():905-921. PubMed ID: 29227931
[TBL] [Abstract][Full Text] [Related]
39. Functionalized chalcones with basic functionalities have antibacterial activity against drug sensitive Staphylococcus aureus.
Liu XL; Xu YJ; Go ML
Eur J Med Chem; 2008 Aug; 43(8):1681-7. PubMed ID: 18031869
[TBL] [Abstract][Full Text] [Related]
40. Antibacterial chalcones--bioisosteric replacement of the 4'-hydroxy group.
Nielsen SF; Boesen T; Larsen M; Schønning K; Kromann H
Bioorg Med Chem; 2004 Jun; 12(11):3047-54. PubMed ID: 15142563
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
